Chemoradiotherapy has edge over radiotherapy alone

摘要

"After induction chemotherapy of two cycles of paditaxel and carboplatin, the addition of simultaneous relatively low-dose weekly paditaxel during radiotherapy enhances efficacy without adding relevant toxic effects", says researcher Rudolf Huber (University of Munich, Germany). He adds that patients who respond during induction chemotherapy also benefit from chemoradiotherapy.